Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Progressive multifocal leukoencephalopathy: cavitary white matter lesions.
On the Historical Succession of Vessel-Based Therapies in the Treatment of Multiple Sclerosis.
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis.
[Chronic cough and worsening dyspnea: a case of idiopathic tracheal stenosis].
New treatments for multiple sclerosis: at what long-term risk?
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Intensive care unit admission in multiple sclerosis: Increased incidence and increased mortality.
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.
Gilenya Safety Update
Vibsanin B Preferentially Targets HSP90β, Inhibits Interstitial Leukocyte Migration, and Ameliorates Experimental Autoimmune Encephalomyelitis.
Effect of comorbidity on mortality in multiple sclerosis.
Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis.
The relationship between cognitive function and high-resolution diffusion tensor MRI of the cingulum bundle in multiple sclerosis.
Month of birth, vitamin D and risk of immune mediated disease: a case control study.
A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis.
[Multiple sclerosis.]
Structural MRI substrates of cognitive impairment in neuromyelitis optica.
Scutellarin Alleviates Behavioral Deficits in a Mouse Model of Multiple Sclerosis, Possibly Through Protecting Neural Stem Cells.
MOG-IgG in neuromyelitis optica.
Disease-specific therapy of idiopathic inflammatory demyelinating disorders.
Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system.
Role of the Human Endogenous Retrovirus HERV-K18 in Autoimmune Disease Susceptibility: Study in the Spanish Population and Meta-Analysis.
Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder.
S1P and the birth of platelets.
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target.

Pages